Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-51518  Pseudomonas aeruginosa, MRSN 552
(Bacteria)
Price: All BEI Resources products are provided
at no cost to registered researchers.
Organism: Pseudomonas aeruginosa
Designations: MRSN 552
Biosafety Level: 2
Availability Status: In Stock
Store at: -60°C or colder
Contributor: MRSN/WRAIR
Comments:
Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

Pseudomonas aeruginosa (P. aeruginosa), strain MRSN 552 was isolated in 2010 from human urine as part of a surveillance program in the United States.

P. aeruginosa, strain MRSN 552 was deposited as part of the MRSN Pseudomonas aeruginosa Diversity Panel available from BEI Resources as NR-51829. NR-51518 was deposited as multi-locus sequence type (MLST) ST 1654, sensitive to amikacin, aztreonam, cefepime, ceftazidime, ciprofloxacin, gentamicin, levofloxacin, piperacillin/ tazobactam and tobramycin and resistant to imipenem and meropenem. Strain MRSN 552 is reported to have a chromosomal aminoglycoside phosphotransferase gene [aph(3')-IIb; conferring resistance to kanamycin A and B, neomycin B and C, butirosin and seldomycin F5], two beta-lactamase genes (blaOXA-50 and blaPAO; conferring resistance to beta-lactams), a chloramphenicol acetyltransferase enzyme gene (cat B7; conferring resistance to chloramphenicol) and a fosfomycin-inactivating gene (fosA; conferring resistance to fosfomycin). The complete genome of P. aeruginosa, strain MRSN 552 is available (GenBank: RXTP00000000).

Note: Environmental and clinical isolates of P. aeruginosa frequently contain viruses known as prophages. During growth, some strains from the Pseudomonas aeruginosa Diversity Panel displayed plaques resulting from the activation of their inherent prophages. Please refer to the Certificate of Analysis to determine if phage plaques were observed for this strain.

Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.

Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
Citations: Acknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Pseudomonas aeruginosa, Strain MRSN 552, NR-51518. This strain is part of the Pseudomonas aeruginosa Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA.”
PERMITS
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

RELATED PRODUCTS
NR-51829
Pseudomonas aeruginosa MRSN Diversity Panel
Return to Top


Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.


Back to My Search